Etiology of thrombocytopenia in all patients treated with heparin products
Authors:
- 5 July 2005
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 75 (2) , 101-105
Abstract
Abstract: Purpose: To characterize the cause of thrombocytopenia in all patients treated with heparin products, to determine the incidence of heparin‐induced thrombocytopenia (HIT) in unselected hospitalized patients, and to have modern data of the magnitude of this problem. Methods: Retrospective hospital‐based cohort study. During a random 2‐month period, we reviewed the medical records of all patients treated with heparin agents, screened them for thrombocytopenia, and determined the cause of it. Results: Out of 674 patients who received heparin products, 110 (16%) had thrombocytopenia. The most common causes included cancer chemotherapy, surgery, sepsis, and medications. Three patients met the clinical criteria for HIT. One had antibodies for heparin‐platelet factor‐4, and received a direct thrombin inhibitor. The other two individuals had a clinical syndrome that resembled immune HIT, but were not tested for HIT antibodies. One suffered a thrombotic episode that led to the death of her fetus. The other died of a possible thromboembolism. Conclusions: This study provides evidence‐based data for the differential diagnosis of thrombocytopenia after treatment with heparin products. Our findings suggest that increased awareness of the HIT syndrome might reduce morbidity and mortality. Patients exposed to heparin products, who develop thrombocytopenia, should not be overlooked.Keywords
This publication has 14 references indexed in Scilit:
- Heparin-Induced ThrombocytopeniaArchives of internal medicine (1960), 2004
- Delayed-Onset Heparin-Induced ThrombocytopeniaAnnals of Internal Medicine, 2003
- The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort studyBlood, 2003
- Delayed-Onset Heparin-Induced ThrombocytopeniaAnnals of Internal Medicine, 2002
- Heparin-Induced Thrombocytopenia-Associated Thrombosis in Pediatric Intensive Care PatientsPediatrics, 2002
- Delayed-Onset Heparin-Induced Thrombocytopenia and ThrombosisAnnals of Internal Medicine, 2001
- Impact of the patient population on the risk for heparin-induced thrombocytopeniaBlood, 2000
- Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight HeparinCirculation, 1999
- Heparin-induced thrombocytopenia in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995